Quantifying the Tendency of Therapeutic Target Proteins to Bind Promiscuous or Selective Compounds
Authors:
Open Access
- 23 May 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0126838
Abstract
The ability of target proteins to bind structurally diverse compounds and compounds with different degrees of promiscuity (multi-target activity) was systematically assessed on the basis of currently available activity data and target annotations. Intuitive first- and second-order target promiscuity indices were introduced to quantify these binding characteristics and relate them to each other. For compounds and targets, opposite promiscuity trends were observed. Furthermore, the analysis detected many targets that interacted with compounds representing a similar degree of structural diversity but displayed strong tendencies to recognize either promiscuous or selective compounds. Moreover, target families were identified that preferentially interacted with promiscuous compounds. Taken together, these findings further extend our understanding of the molecular basis of polypharmacology.Keywords
This publication has 12 references indexed in Scilit:
- The ChEMBL bioactivity database: an updateNucleic Acids Research, 2013
- Polypharmacology – Foe or Friend?Journal of Medicinal Chemistry, 2013
- Compound promiscuity: what can we learn from current data?Drug Discovery Today, 2013
- On the origins of drug polypharmacologyMedChemComm, 2012
- How Promiscuous Are Pharmaceutically Relevant Compounds? A Data-Driven AssessmentThe AAPS Journal, 2012
- Reorganizing the protein space at the Universal Protein Resource (UniProt)Nucleic Acids Research, 2011
- Global assessment of scaffold hopping potential for current pharmaceutical targetsMedChemComm, 2010
- Network pharmacology: the next paradigm in drug discoveryNature Chemical Biology, 2008
- Global mapping of pharmacological spaceNature Biotechnology, 2006
- The Properties of Known Drugs. 1. Molecular FrameworksJournal of Medicinal Chemistry, 1996